AB-RayBio
Latest round
- Angel
Last raised
- Jun 2025
Total raised
- Undisclosed
Investors
- 3
About AB-RayBio
, trading as AB-RayBio, focuses on innovative biopharmaceutical solutions for cancer treatment. The company specializes in the research and development of innovative targeted radiopharmaceuticals, specifically designed to address unmet clinical needs in oncology. The company is currently in the clinical research phase, working on novel therapeutic options for cancer patients and enhancing treatment choices. They utilize a technology platform that includes small molecule discovery, AI-driven peptide high-throughput screening, radiopharmaceutical labeling, quality research, non-clinical evaluation, and rapid clinical translation. The primary end-users are healthcare providers and institutions that treat cancer patients, targeting markets in regions with high cancer prevalence. The financial operations of the company are structured around partnerships and direct collaborations with healthcare institutions and research organizations. The company engages in B2B transactions, supplying its radiopharmaceutical products to hospitals and cancer treatment centers. Pricing is established based on contracts reflecting the value of their innovative treatments, supporting the delivery of core products designed to enhance therapeutic outcomes for patients with cancer, although specific pricing details and revenue figures are not disclosed.
Who invested in AB-RayBio
3 investors across 1 round
See all investors in AB-RayBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jun 13, 2025
Amount
Undisclosed
Investors
Questions about AB-RayBio
Who invested in AB-RayBio?
AB-RayBio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AB-RayBio raised?
AB-RayBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AB-RayBio last raise money?
AB-RayBio's most recent round on record is a Angel, in Jun 2025.
What does AB-RayBio do?
, trading as AB-RayBio, focuses on innovative biopharmaceutical solutions for cancer treatment.
Where is AB-RayBio headquartered?
AB-RayBio is headquartered in Hangzhou, China.
Which VCs invest in companies like AB-RayBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at AB-RayBio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like AB-RayBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.